Fundraising Archives

Best in Biotech 17 Oct 2024

Top six European biotech entrepreneurs to know in 2024 (according to VCs)

We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market.

October 17, 2024 - 8 minutesmins - By Roohi Mariam Peter

Inside Labiotech 3 Jul 2024

2024 survey: What can Labiotech readers tell us about the biotech industry?

Explore key insights into the latest biotech industry trends based on our 2024 reader survey findings. Discover more now!

July 3, 2024 - 4 minutesmins - By Joachim Eeckhout

In Depth 28 Feb 2024

Beyond fundraising: how do venture capitals build early-stage biotechs?

Venture capitals can help build early-stage biotech startups and boost innovation in the life science industry.

February 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 14 Dec 2023

Seven companies shaping the future of precision medicine

Explore the forefront of healthcare innovation with these seven cutting-edge biopharma companies specializing in precision medicine.

December 14, 2023 - 9 minutesmins - By Roohi Mariam Peter

Weekly Roundup 8 Dec 2023

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

December 8, 2023 - 14 minutesmins - By Willow Shah-Neville

News and Trends 1 Dec 2023

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

Here is Labiotech’s weekly roundup of the latest biotech news. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. The latest biotech news in fundraising In the news this week, biotech Arvinas raises $350 million PIPE American protein degradation company Arvinas has bagged $350 million in a private placement (PIPE). The […]

December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. Viva Biotech closes $210 million funding round Chinese company Viva Biotech closed a funding round worth $210 […]

November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

In Depth 16 Oct 2023

Blockchain-based biotech: is this a viable financing method?

At a time when biotechs are scrambling to raise funds, a new way for startups to secure investments is emerging: leveraging cryptocurrency. The motive behind decentralized financing seems pretty ambitious – to democratize funding in healthcare. But does it live up to the hype? With VitaDAO – a decentralized collective that funds early-stage startups looking […]

October 16, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

This past year has not been very sympathetic to fundraisers in the biotech industry. As the economic downturn grinds on, many companies are in need of funds to stay afloat. A recent trend in the way biotechs have secured funding, might be telling of how these companies are determined to pull through. A private investment […]

October 2, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 6 Mar 2023

The biggest private biotech investments in February 2023

The companies Aera Therapeutics, Hemab and Loam Bio bagged the biggest biotech investments in February 2023. Around the world, gene therapy, manufacturing and biomaterials attracted the most investor interest. Private biotech fundraising in February 2023 lacked the massive funding rounds seen in January, from the likes of Asimov and BioRay Pharmaceuticals. However, there was still […]

March 6, 2023 - 4 minutesmins - By Jonathan Smith

In Depth 6 Feb 2023

The biggest private biotech investments in January 2023

The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January 2023. Around the world, synthetic biology players and firms developing treatments for hormonal disorders attracted the biggest funding rounds. 2023 began with a bang in terms of biotech funding, and there are signs of stabilization in biotech stocks after two […]

February 6, 2023 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Fundraising

Top six European biotech entrepreneurs to know in 2024 (according to VCs)

2024 survey: What can Labiotech readers tell us about the biotech industry?

Beyond fundraising: how do venture capitals build early-stage biotechs?

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

Seven companies shaping the future of precision medicine

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Blockchain-based biotech: is this a viable financing method?

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

The biggest private biotech investments in February 2023

The biggest private biotech investments in January 2023

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!